Mohs Micrographic Surgery in Skin of Color

May 2022 | Volume 21 | Issue 5 | Features | 536 | Copyright © May 2022


Published online May 1, 2022

Ramone F. Williams MD MPhil,a,b David Ciocon MDc,d

aMassachusetts General Hospital, Department of Dermatology, Boston, MA
bHarvard Medical School, Boston, MA
cAlbert Einstein College of Medicine, Division of Dermatology, Bronx, NY
dMontefiore Medical Center, Division of Dermatology, Bronx, NY



use non-ablative fractional erbium 1550 nm laser resurfacing for scar rejuvenation in patients with type IV through VI skin. When using low fluences, we have observed reproducibly safe and effective outcomes. For keloids, we use a combination of intralesional triamcinolone with non-ablative erbium 1550 nm laser resurfacing with satisfactory results.

SUMMARY

In summary, there is a paucity of meaningful data on MMS in patients with skin of color. We have outlined some of the potential surgical complications unique to this population, as well as guidance for mitigation and management.

DISCLOSURES

The authors have no conflicts of interest to disclose.

REFERENCES

1. Colby SL, Ortman JM. Projections of the Size and Composition of the U.S. Population: 2014 to 2060. U.S. Census Bureau March 2015. 2. Reeder VJ, Gustafson CJ, Mireku K, Davis SA, Feldman SR, Pearce DJ. Trends in Mohs surgery from 1995 to 2010: an analysis of nationally representative data. Dermatol Surg. 2015;41(3):397-403.
3. Higgins S, Nazemi A, Chow M, Wysong A. Review of nonmelanoma skin cancer in African Americans, Hispanics, and Asians. Dermatol Surg. 2018;44(7):903-910.
4. Gupta R, Gordon SL, Council ML, Hurst EA. Clinical characteristics of basal cell carcinoma in African Americans: A 10-year retrospective review at a single academic institution. Dermatol Surg. 2019;45(5):660-665.
5. Loh TY, Ortiz A, Goldenberg A, Brian Jiang SI. Prevalence and clinical characteristics of nonmelanoma skin cancers among Hispanic and Asian patients compared with white patients in the United States: A 5-year, singleinstitution retrospective review. Dermatol Surg. 2016;42(5):639-645.
6. Perper M, Shah V, Tsatalis J, Eber AE, Zheng C, Nouri K. Keratinocyte carcinoma data for Hispanic patients undergoing Mohs micrographic surgery in Miami, Florida from 2011 to 2014. J Am Acad Dermatol. 2017;77(3):580- 582.
7. Ro KW, Seo SH, Son SW, Kim IH. Subclinical infiltration of Basal cell carcinoma in asian patients: assessment after mohs micrographic surgery. Ann Dermatol. 2011;23(3):276-281.
8. Adotama P, Papac N, Alexis A, Wysong A, Collins L. Common dermatologic procedures and the associated complications unique to skin of color. Dermatol Surg. 2021;47(3):355-359.
9. Kornmehl H, Singh S, Adler BL, Wolf AE, Bochner DA, Armstrong AW. Characteristics of medical liability claims against dermatologists from 1991 through 2015. JAMA Dermatol. 2018;154(2):160-166.
10. Silpa-Archa N, Kohli I, Chaowattanapanit S, Lim HW, Hamzavi I. Postinflammatory hyperpigmentation: A comprehensive overview: